Not applicableUnknownNCT02227953What this trial is testingA Pilot Study of tDCS for Mild to Moderate Alzhemier's DiseaseWho this might be right forAlzheimer's Disease Samsung Medical Center 20
Not applicableStudy completedNCT05637801What this trial is testingA Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)Who this might be right forAlzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more Cognito Therapeutics, Inc. 673
Large-scale testing (Phase 3)Study completedNCT00506415What this trial is testingComparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive DeclineWho this might be right forAlzheimer Disease Novartis Pharmaceuticals 1,584
Testing effectiveness (Phase 2)UnknownNCT03865017What this trial is testingA Safety and Tolerability Study of GB301Who this might be right forAlzheimer Disease VTBIO Co. LTD 20
Large-scale testing (Phase 3)Study completedNCT00829374What this trial is testingSafety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on DonepezilWho this might be right forAlzheimer's Disease Medivation, Inc. 1,003
Testing effectiveness (Phase 2)Ended earlyNCT01238991What this trial is testingLong Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 53
Early research (Phase 1)Study completedNCT01485302What this trial is testingSingle and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's PatientsWho this might be right forAlzheimer's Disease Sanofi 48
Testing effectiveness (Phase 2)Study completedNCT03867253What this trial is testingTesting the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's DiseaseWho this might be right forMild to Moderate Alzheimer's Disease Oryzon Genomics S.A. 24
Testing effectiveness (Phase 2)Study completedNCT01018875What this trial is testingEfficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 242
Not applicableUnknownNCT06008639What this trial is testingEfficacy and Safety of Near Infrared Light Therapy for Alzheimer's DiseaseWho this might be right forMild to Moderate Alzheimer's Disease Danyang Huichuang Medical Equipment Co., Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT03038035What this trial is testingThe Alzheimer's Disease THErapy With NEuroaid (ATHENE) StudyWho this might be right forAlzheimer Disease National University Hospital, Singapore 150
Testing effectiveness (Phase 2)Ended earlyNCT00916617What this trial is testingStudy Evaluating The Long-Term Safety And Efficacy Of Subcutaneous BapineuzumabWho this might be right forAlzheimer Disease Pfizer 62
Large-scale testing (Phase 3)WithdrawnNCT01211782What this trial is testingAC-1204 Long-term Efficacy Response Trial (ALERT Protocol)Who this might be right forAlzheimer's Disease Cerecin
Testing effectiveness (Phase 2)UnknownNCT01569516What this trial is testingStudy of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Changchun Huayang High-tech Co., Ltd 288
Early research (Phase 1)Study completedNCT01850238What this trial is testingSafety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's DiseaseWho this might be right forAlzheimer Disease Axon Neuroscience SE 30
Early research (Phase 1)Study completedNCT05667649What this trial is testingAutologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Regeneration Biomedical, Inc. 7
Early research (Phase 1)WithdrawnNCT03316898What this trial is testingA FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Allergan
Not applicableStudy completedNCT01796314What this trial is testingImpact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of LifeWho this might be right forAlzheimer Disease University Hospital, Toulouse 170
Large-scale testing (Phase 3)Study completedNCT00053599What this trial is testingCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyWho this might be right forAlzheimer Disease National Institute on Aging (NIA) 400
Early research (Phase 1)Study completedNCT02434718What this trial is testingSingle and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Biogen 21